News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
757,496 Results
Type
Article (73778)
Company Profile (243)
Press Release (683475)
Section
Business (213658)
Career Advice (3193)
Deals (37234)
Drug Delivery (112)
Drug Development (86349)
Employer Resources (178)
FDA (16916)
Job Trends (16347)
News (365884)
Policy (36034)
Tag
Academia (2937)
Alliances (53619)
Alzheimer's disease (1303)
Approvals (16825)
Artificial intelligence (143)
Bankruptcy (337)
Best Places to Work (12046)
Biotechnology (132)
Breast cancer (116)
Cancer (1001)
Cardiovascular disease (89)
Career advice (2695)
Cell therapy (237)
Clinical research (67797)
Collaboration (360)
Compensation (143)
COVID-19 (2753)
C-suite (92)
Data (928)
Diabetes (150)
Diagnostics (6428)
Drug pricing (97)
Earnings (81953)
Employer resources (155)
Events (115169)
Executive appointments (267)
FDA (17390)
Funding (311)
Gene therapy (173)
GLP-1 (649)
Government (4897)
Healthcare (19943)
Infectious disease (2832)
Inflammatory bowel disease (111)
Interviews (602)
IPO (16587)
Job creations (4625)
Job search strategy (2263)
Layoffs (472)
Legal (8767)
Lung cancer (162)
Manufacturing (181)
Medical device (13730)
Medtech (13735)
Mergers & acquisitions (20698)
Metabolic disorders (414)
Neuroscience (1565)
NextGen Class of 2024 (7125)
Non-profit (4974)
Northern California (1263)
Obesity (242)
Opinion (236)
Patents (102)
People (61854)
Phase I (20852)
Phase II (29575)
Phase III (22274)
Pipeline (270)
Postmarket research (3189)
Preclinical (9470)
Radiopharmaceuticals (254)
Rare diseases (209)
Real estate (6984)
Regulatory (23690)
Research institute (2611)
Resumes & cover letters (491)
Southern California (1137)
Startups (3770)
United States (12268)
Vaccines (614)
Weight loss (197)
Date
Today (267)
Last 7 days (962)
Last 30 days (3325)
Last 365 days (36467)
2024 (31726)
2023 (40957)
2022 (52200)
2021 (57202)
2020 (56262)
2019 (49908)
2018 (38006)
2017 (35281)
2016 (35662)
2015 (41730)
2014 (35846)
2013 (32218)
2012 (33741)
2011 (33846)
2010 (33031)
Location
Africa (1080)
Arizona (181)
Asia (45377)
Australia (7835)
California (2824)
Canada (1193)
China (224)
Colorado (126)
Connecticut (138)
Europe (102757)
Florida (410)
Georgia (109)
Illinois (359)
Indiana (192)
Kansas (98)
Maryland (556)
Massachusetts (2298)
Michigan (148)
Minnesota (250)
New Jersey (875)
New York (872)
North Carolina (757)
Northern California (1263)
Ohio (134)
Pennsylvania (752)
South America (1465)
Southern California (1137)
Texas (405)
Washington State (333)
757,496 Results for "pharmaceutical research and manufacturers of america phrma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legal
Appeals Court Breathes New Life Into PhRMA’s Legal Challenge to IRA
A lawsuit filed by the Pharmaceutical Research and Manufacturers of America, which claims the Inflation Reduction Act’s Medicare Drug Price Negotiation Program is unconstitutional, now goes back to a lower Texas court.
September 23, 2024
·
2 min read
·
Tristan Manalac
Podcast
Novo Grilled by Senate, PhRMA’s IRA Win and BMS’ KarXT Awaits Approval
New revelations from the showdown between Novo Nordisk’s CEO and Bernie Sanders’ Senate health committee Tuesday; PhRMA’s legal victory in IRA case; the federal interest rate cut and anticipated approval for schizophrenia.
September 25, 2024
·
1 min read
·
Heather McKenzie
Policy
PhRMA Loses Another Legal Battle as Court Sides with Arkansas Over Drug Discount Program
A lawsuit filed by the Pharmaceutical Research and Manufacturers of America failed to block an Arkansas law that empowers hospitals to use outside pharmacies to dispense discounted drugs.
March 14, 2024
·
2 min read
·
Tristan Manalac
Policy
Texas Court Dismisses PhRMA IRA Lawsuit Against Biden Administration
On Monday, the Biden administration got an early victory in pharma’s legal challenge to the Inflation Reduction Act, with a Texas judge dismissing a complaint from the Pharmaceutical Research and Manufacturers of America.
February 13, 2024
·
2 min read
·
Tristan Manalac
Policy
PhRMA Names Gilead CEO O’Day as New Board Chair Following Loss of Members
With the departure of AbbVie and AstraZeneca from the trade group, Pharmaceutical Research and Manufacturers of America has named new members to its leadership including Gilead Sciences chief Daniel O’Day.
February 22, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Mitsubishi Tanabe Pharma America to Showcase ALS Research at 2024 AANEM Annual Meeting
October 16, 2024
·
7 min read
Business
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America
Crossject announces the appointment of the experienced life sciences executive and medical affairs and clinical research specialist Dan Chiche, MD as Chief Medical Officer North America.
June 12, 2024
·
3 min read
Press Releases
Mitsubishi Tanabe Pharma America Unveils New ALS Research Findings at NEALS 2024 Annual Meeting
October 18, 2024
·
10 min read
Press Releases
Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America
September 27, 2024
·
3 min read
Opinion
Invest in Domestic Manufacturing to Onshore America’s Biotech Supply Chain
As the U.S. moves away from reliance on Chinese CDMOs, Southern cities provide a model for how we can bolster domestic production capacity.
August 14, 2024
·
5 min read
·
Josh Carpenter
1 of 75,750
Next
